Business Context and Reporting Period
This Form 8-K is filed by Angion Biomedica Corp. (not Elicio Therapeutics, Inc.) on March 30, 2021. The report announces financial results for the fiscal quarter and full year ended December 31, 2020. The company is an emerging growth company incorporated in Delaware, with common stock trading on the Nasdaq Global Select Market under the symbol ANGN.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the press release furnished as Exhibit 99.1, which is incorporated by reference but not detailed in the body of this 8-K document.
Material Changes
The filing does not explicitly detail material changes versus prior periods within the text provided. It serves solely as a notification that the results for the fourth quarter and full year 2020 have been released via a separate press release.
Guidance, Outlook, and Risks
Management Commentary and Guidance: The filing does not contain specific guidance or outlook statements; it refers investors to the press release (Exhibit 99.1) for the full announcement.
Risks and Contingencies: No specific risks or contingencies are detailed in this 8-K text. The document includes a standard disclaimer stating that the information furnished under Item 2.02 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not subject to the liabilities of that section.
Investor Verification Checklist
- Verify the specific financial figures (revenue, net loss, cash position) by reviewing Exhibit 99.1 (the press release dated March 30, 2021).
- Confirm the company name is Angion Biomedica Corp. (ANGN), as the request metadata incorrectly listed Elicio Therapeutics, Inc.
- Review the full press release for any forward-looking statements or operational updates not captured in this summary 8-K.
- Note that the information in this 8-K is not legally "filed" under Section 18 of the Exchange Act, limiting liability for the referenced data.